Intersect ENT, Inc. announced that Lisa Earnhardt will be stepping down from her role as Chief Executive Officer on June 5, 2019 to accept another opportunity. Kieran Gallahue, the company's Lead Director, has been appointed Executive Chairman of the Board of Directors, effective May 7, 2019, and Interim Chief Executive Officer, effective June 5, 2019. Ms. Earnhardt will remain a member of the Intersect ENT Board.

Simultaneously with Mr. Gallahue's appointment as Executive Chairman of the Board, he has resigned from the Company's Audit Committee and the Board has appointed Teresa L. Kline to serve on the Audit Committee.